Myriad Genetics
$1.72 B
Share price
Change (1 day)
Change (1 year)

Market capitalization of Myriad Genetics (MYGN)

Market cap: $1.72 Billion

As of May 2022 Myriad Genetics has a market cap of $1.72 Billion. This makes Myriad Genetics the world's 3703th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Myriad Genetics from 2001 to 2022

Year Market cap Change
2022$1.79 B-18.45%
2021$2.20 B47.82%
2020$1.49 B-26.5%
2019$2.02 B-4.67%
2018$2.12 B-10.52%
2017$2.37 B108.51%
2016$1.14 B-63.09%
2015$3.09 B26.86%
2014$2.43 B56.96%
2013$1.55 B-29.95%
2012$2.21 B24.88%
2011$1.77 B-13.82%
2010$2.05 B-18.12%
2009$2.51 B-18.4%
2008$3.08 B49.62%
2007$2.05 B64.9%
2006$1.24 B53.44%
2005$0.81 B17.69%
2004$0.69 B98.13%
2003$0.34 B-11.49%
2002$0.39 B-68.45%
2001$1.25 B

End of Day market cap according to different sources

On May 19th, 2022 the market cap of Myriad Genetics was reported to be:

$1.73 Billion
by Nasdaq
$1.73 Billion
by CompaniesMarketCap
$1.72 Billion
by Yahoo Finance
$1.73 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$197.30 B 11,322.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.37 B 443.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.92 B 763.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.02 B-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$15.86 B 818.19%๐Ÿ‡บ๐Ÿ‡ธ USA